09:40 AM EST - Bausch Health Companies Inc. : Said its Bausch + Lomb eye-health business announced that BASES, a Nielsen Global Consumer business division, has named LUMIFY® (brimonidine tartrate ophthalmic solution 0.025%) redness reliever eye drops to its 2020 U.S. BASES Top 25 Breakthrough Innovations List in the "Superstar" category for its success in driving sales and category growth. The Top 25 Breakthrough Innovations List has been the gold standard for nearly a decade in recognizing innovation and global success within the Consumer Packaged Goods (CPG) space. Bausch Health Companies Inc.
shares T.BHC are trading unchanged at $20.70.
